Skinvisible, Inc. financial data

Symbol
SKVI on OTC
Location
6320 S Sandhill Road, Unit 9, Las Vegas, NV
State of incorporation
Nevada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.04 % -64.4%
Debt-to-equity -102 % +1.3%
Return On Equity 12.9 % -63.5%
Return On Assets -714 % +36.6%
Operating Margin -2.58K % -29.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.89M shares +7.71%
Common Stock, Shares, Outstanding 4.89M shares +7.71%
Entity Public Float 400K USD -27.4%
Common Stock, Value, Issued 4.89K USD +7.71%
Weighted Average Number of Shares Outstanding, Basic 4.54M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 4.64M shares +2.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20K USD -17.8%
Cost of Revenue 3.3K USD
Operating Income (Loss) -516K USD -6.16%
Net Income (Loss) Attributable to Parent -1.19M USD +54.6%
Earnings Per Share, Diluted -0.26 USD/shares +54.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 5K USD
Assets, Current 35.9K USD -39.8%
Assets 163K USD -16.9%
Liabilities, Current 4.02M USD +35%
Liabilities 9.74M USD +12.9%
Retained Earnings (Accumulated Deficit) -40M USD -3.06%
Stockholders' Equity Attributable to Parent -9.58M USD -13.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9.58M USD -13.6%
Liabilities and Equity 163K USD -16.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.3K USD +76.2%
Net Cash Provided by (Used in) Financing Activities 19.5K USD
Net Cash Provided by (Used in) Investing Activities -525 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 4.89M shares +7.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.21K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.99K USD +97%
Deferred Tax Assets, Gross 8.3M USD +6.41%
Additional Paid in Capital 30.4M USD +0.11%
Amortization of Intangible Assets 4.7K USD +1.1%
Interest Expense 669K USD -68.7%